Abstract: The invention relates to electronic indexing, and more particularly, to the indexing, in a cloud, data held in a cloud. Systems and methods of the invention index data by accessing the data in place in the cloud and breaking a job into work items and sending the work items to multiple cloud processes that can each determine whether to index data associated with the work item or to create a new work item and have a different cloud process index the data. Each cloud process is proximal to an item that it indexes. This gives the system scale as well as an internal load-balancing.

Abstract: A pass-through hand tool includes a handle that includes a hollow bore extending therethrough. The tool includes a reversible main barrel, having a pair of socket ends and a hollow interior. The reversible main barrel is insertable into the hollow bore in either of two orientations to present one of the sockets. The tool includes a reversible secondary barrel having another pair of sockets, an external hexagonal screwdriver head, and a hollow secondary interior. The reversible secondary barrel is insertable into the hollow interior of the reversible main barrel in either of two orientations to present one of the associated sockets. The tool includes a reversible tertiary barrel having another pair of sockets with external hexagonal screwdriver heads and a hollow tertiary interior. The reversible tertiary barrel is insertable into the hollow interior of the reversible secondary barrel in either of two orientations to present one of the associated sockets.

Abstract: A portable structure including a base, a first wall panel and a second wall panel. The base includes a first post and a second post. The first wall panel includes a first outer corner extrusion and a second outer corner extrusion, the first outer corner extrusion adapted to partially enclose the first post and the second outer corner extrusion adapted to partially enclose the second post. The second wall panel includes a first inner corner extrusion adapted to fully enclose the first post when used in combination with the first outer corner extrusion.

Abstract: A portable structure including a base, a first wall panel and a second wall panel. The base includes a first post and a second post. The first wall panel includes a first outer corner extrusion and a second outer corner extrusion, the first outer corner extrusion adapted to partially enclose the first post and the second outer corner extrusion adapted to partially enclose the second post. The second wall panel includes a first inner corner extrusion adapted to fully enclose the first post when used in combination with the first outer corner extrusion.

Abstract: A receptacle for storing cremated remains, the receptacle comprising an elongate hollow tower, means for securing the tower in the ground, a lockable cover or door for getting access to the interior of the elongate hollow tower wherein a plurality of cremated remains holders can be stacked on another.

Abstract: A portable mechanism that can be inserted into the rear portion of a gasoline-dispensing nozzle to automate the open position of that nozzle. This portable mechanism also disables the user from returning the gasoline-dispensing nozzle back into its resting cradle without removing the portable mechanism.

Abstract: A method, system, and software of relating structured data to unstructured data includes displaying unstructured data in a first display area and displaying structured data related to the unstructured data in a second display area. In response to a change in the display of one of the unstructured data in the first display area or the structured data in the second display area, automatically dynamically changing the display in the other of the first display area or the second display area to display changed data based on its relation to the changed data in the one of the first display area or the second display area.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: This invention relates to methods and kits for measuring ?-amylase activity in samples such as flour, stock, or amylase concentrate.

Abstract: Hapten-carrier conjugates capable of eliciting anti-hapten antibodies in vivo by administering, in a therapeutic composition, are, disclosed. Methods of preparing said conjugates and therapeutic compositions are also disclosed. Where the hapten is a drug of abuse, a therapeutic composition containing the hapten-carrier conjugate is particularly useful in the treatment of drug addiction, more particularly, cocaine addiction. Passive immunization using antibodies raised against conjugates of the instant invention is also disclosed. The therapeutic composition is suitable for co-therapy with other conventional drugs.

Abstract: The present invention relates to systems and methods that manage a state machine's wake state to facilitate power management. The systems and methods comprise a state manager that can be employed to receive signals transmitted to a state machine that has transitioned to a lower power state. Thus, when a signal is transmitted to the state machine, the state manager can initially receive the signal rather the state machine. The state manager can interpret the signal and determine whether a low power coprocessor can respond to the signal. If the low power coprocessor can respond, then the coprocessor responds while the state machines remains in the lower power state. The system and methods can be concurrently employed by a plurality of state machines residing on similar and/or disparate networks, buses, backplanes, etc. The foregoing facilitates state machine power consumption reduction while maintaining timely responses.

Abstract: The present invention provides nucleic acid sequences coding for the Cryptomeria japonica major pollen allergen Cry j I, Cry j II, Jun s I and Jun v I and fragments or peptides thereof. The present invention also provides purified Cry j I, Cry j II, Jun s I and Jun v I and at least one fragment thereof produced in a host cell transformed with a nucleic acid sequence coding for Cry j I, Cry j II, Jun s I and Jun v I or at least one fragment thereof, and fragments of Cry j I, Cry j II, Jun s I or Jun v I or at least one fragment thereof, and fragments of Cry j I, Cry j II, Jun s I or Jun v I prepared synthetically. Cry j I, Cry j II, Jun s I and Jun v I and fragments thereof are useful for diagnosing, treating, and preventing Japanese cedar pollinosis. The present invention also provides isolated peptides of Cry j I and Cry j II. Peptides within the scope of the invention comprise at least one T cell epitope, or preferably at least two T cell epitopes of Cry j I or Cry j II.